BioSpace News Archive

Axonics Modulation Technologies, Inc. announced the approval of the Axonics r-SNM® System by the United States Food & Drug Administration.

Aptorum Group Limited, a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces the development of two preclinical drug candidates which target obesity and neuroblastoma, respectively.

Merck announced new data from its broad oncology portfolio and pipeline will be presented at the European Society for Medical Oncology 2019 Congress in Barcelona, Spain, from Sept. 27-Oct. 1, 2019.

Award-winning healthcare design innovation firm named as a winner in Health category and honorable mention in General Excellence category amongst 4,300 applicants

Theravance Biopharma, Inc. announced initial results, including positive biomarker responses, from its Phase 1 single-ascending dose and multiple-ascending dose clinical trial of TD-8236, an investigational, lung-selective inhaled pan-Janus kinase inhibitor for inflammatory lung diseases.

STAAR Surgical Company is announcing the EVO ICL Clinical Program which will be presented by Ophthalmic Surgeons to Ophthalmic Surgeons at its invitation only Surgical Experts Summit.

Dr. Coles assumes his new role at an important time as the company prepares to launch six clinical trials by the end of 2020 to advance its robust and diverse neuroscience pipeline

KalVista Pharmaceuticals, Inc. provided an operational update and released financial results for the fiscal first quarter ended July 31, 2019.

Proliant Biologicals, LLC (Proliant), an LGI company (Lauridsen Group Inc.), today announced that it has acquired Boval BioSolutions from Lifecycle Biotechnologies of Fort Worth, TX.

Rapid Acoustic Pulse (“RAP”) Technology has the Potential of Disrupting the Multi-Billion Dollar Global Aesthetics Industry [09-September-2019] HOUSTON , Sept. 9, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) (“Soliton” or the “Company”), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on